Acadia Pharmaceuticals | ACAD - دارایی ها





دارایی ها تغییر دادن تاریخ
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
ALKERMES USD 2.49B 157.48M 2025-12
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Cara Therapeutics USD 39.02M 4.73M 2025-09
Corcept Therapeutics USD 836.65M 13.04M 2025-12
Cytokinetics USD 1.42B 12.02M 2025-12
Eisai JPY 1.49T 48.22B 2025-12
Eli Lilly USD 112.48B 2.46B 2025-12
Incyte USD 6.96B 627.62M 2025-12
J&J USD 199.21B 6.39B 2025-12
Moderna USD 12.34B 203M 2025-12
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Prothena USD 326.8M 25.82M 2025-12
PTC Therapeutics USD 2.9B 255.07M 2025-12
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12